Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. All 

requests should be identified by the title 

of the information collection. Email 

address: infocollection@acf.hhs.gov. 

OMB Comment 

OMB is required to make a decision 

concerning the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. Written comments and 

recommendations for the proposed 

information collection should be sent 

directly to the following: Office of 

Management and Budget, Paperwork 

Reduction Project, Email: OIRA_

SUBMISSION@OMB.EOP.GOV. Attn: 

Desk Officer for the Administration for 

Children and Families. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2015–25737 Filed 10–8–15; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Request for Information From NonFederal Stakeholders on Progress and 

Accomplishments (2010–2015) 

Towards the Goals of the National 

Vaccine Plan 

AGENCY: National Vaccine Program 

Office, Office of the Assistant Secretary 

for Health, Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: The development of a 

National Vaccine Plan was mandated by 

Congress as a mechanism for the 

Director of the National Vaccine 

Program (the Assistant Secretary for 

Health) to communicate priorities for 

achieving the Program’s responsibilities 

of ensuring adequate supply of and 

access to vaccines and ensuring the 

effective and optimal use of vaccines. 

The National Vaccine Plan, released in 

2010, provides a comprehensive 10-year 

national strategy for enhancing all 

aspects of the National Vaccine Program 

including: Research and development, 

supply, financing, distribution, safety, 

informed decision making by consumers 

and health care providers, vaccine 

preventable disease surveillance, 

vaccine effectiveness and use 

monitoring, and global cooperation 

(http://www.hhs.gov/nvpo/vacc_plan/ 

index.html). 

In accordance with the 2010 National 

Vaccine Plan (NVP), the National 

Vaccine Program Office (NVPO) is 


tkelley on DSK3SPTVN1PROD with NOTICES

61214 Federal Register / Vol. 80, No. 196 / Friday, October 9, 2015 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from the Hooker 

Electrochemical Corporation in Niagara 

Falls, New York, as an addition to the 

Special Exposure Cohort (SEC) under 

the Energy Employees Occupational 

Illness Compensation Program Act of 

2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 1090 Tusculum Avenue, MS C– 

46, Cincinnati, OH 45226–1938, 

Telephone 1–877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: 

Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 

7384l(14)(C). 

On September 22, 2015, as provided 

for under 42 U.S.C. 7384l(14)(C),the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

‘‘All Atomic Weapons Employees who 

worked at the Hooker Electrochemical 

Corporation in Niagara Falls, New York, 

during the operational period from July 1, 

1944, through December 31, 1948, for a 

number of work days aggregating at least 250 

work days, occurring either solely under this 

employment or in combination with work 

days within the parameters established for 

one or more other classes of employees in the 

Special Exposure Cohort.’’ 

This designation will become 

effective on October 22, 2015, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2015–25757 Filed 10–8–15; 8:45 am] 

BILLING CODE 4163–19–P 

conducting a mid-course review of the 

Plan following five years of its 

implementation. This review is 

intended to ensure that the priorities 

and activities outlined in the NVP are 

appropriately aligned towards the goals 

described therein given significant 

changes in the immunization landscape 

that have occurred since the NVP was 

released in 2010. 

The NVP is intended to be a national 

plan that includes contributions from 

both federal and non-federal 

stakeholders. In order to collect 

information from non-federal 

stakeholders in a uniform and 

systematic way, the NVPO is issuing a 

Request for Information (RFI) through a 

structured survey accessed on the NVPO 

Web site at http://www.hhs.gov/nvpo/ 

vacc_plan/index.html#mid-coursereview. The RFI will solicit specific 

information regarding the priorities, 

goals, and objectives within the NVP, 

significant accomplishments since 2010, 

remaining gaps, and stakeholder 

perspectives on priorities of the vaccine 

and immunization community for the 

remaining years of the NVP (2016– 

2020). Finally, stakeholders will also be 

provided the opportunity to briefly 

inform NVPO of the top contributions 

from their organization. 

DATES: Survey responses on the 

National Vaccine Plan must be 

completed and submitted online by 

midnight, 12:00 a.m. EDT on November 

9, 2015. 

ADDRESSES: All those interested in 

participating in the survey to provide 

information on the National Vaccine 

Plan should do so by clicking on the 

survey link provided on the NVPO Web 

site at http://www.hhs.gov/nvpo/vacc_

plan/index.html#mid-course-review. 

FOR FURTHER INFORMATION CONTACT: 

National Vaccine Program Office, Office 

of the Assistant Secretary for Health, 

Department of Health and Human 

Services; telephone (202) 690–5566; 

email: nvpo@hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

The National Vaccine Program was 

established in compliance with Title 

XXI of the Public Health Service Act 

(Pub. L. 99–660) (§ 2101) (42 U.S. Code 

300aa–et seq (PDF—78 KB)) to achieve 

optimal prevention of human infectious 

diseases through immunization and to 

achieve optimal prevention against 

adverse reactions to vaccines. 

Development of a National Vaccine Plan 

has been mandated to the National 

Vaccine Program Office as a mechanism 

for the Director of the National Vaccine 

Program (the Assistant Secretary for